@article{f1e64cc593234e5e89fe4d49a6c8bef4,
title = "Potential Survival Gains from First-line (1L) Systemic Therapy Advances in Metastatic Triple-negative Breast Cancer (mTNBC)",
author = "Reshma Mahtani and P. Bajaj and J. Roth and S. Sullivan and A. Stein and S. Ramsey",
note = "Background: Approximately 15\% of the 67,000 women diagnosed with metastatic breast cancer (mBC) annually in the U.S. have mTNBC. Few effective treatment options for mTNBC patients have been identified in the past decade \& outcomes are poor vs. other mBC subtypes.",
year = "2018",
language = "American English",
volume = "29",
journal = "Annals of Oncology / 43rd. European Society for Medical Oncology. ESMO Congress",
}